Acamprosate Calcium
NDC 69452-353, Acamprosate Calcium, tablet, delayed release, from Bionpharma Inc.,.
- Product NDC
- 69452-353
- Status
- Listed
- Labeler
- Bionpharma Inc.,
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219904
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-353 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACAMPROSATE CALCIUM333 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-353-25 | 69452035325 | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (69452-353-25) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4473326f-79f1-61b2-e063-6294a90a17a3NADAC price for package 69452035325
GET /v1/drugs/nadac/69452035325
Use it
Look up 69452-353 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-353 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-353. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.